Dupilumab in Cholinergic Urticaria: An Exploratory Phase 2 Investigator-Initiated Study.
- DOI
- 10.1111/all.70454
- Published
- 2026 Jul 31
- Container
- Allergy
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/all.70454,
title = {Dupilumab in Cholinergic Urticaria: An Exploratory Phase 2 Investigator-Initiated Study.},
author = {Gutsche A and Grabowska W and Altrichter S and Grekowitz E and Roll S and Heine G and Staubach P and Pfützner W and Brehler R and Bauer A and Wagner N and Wurpts G and Salameh P and Salehzadeh-Yazdi A and Jahandideh SS and Metz M},
year = {2026},
journal = {Allergy},
doi = {10.1111/all.70454},
url = {https://doi.org/10.1111/all.70454}
}RIS
TY - JOUR TI - Dupilumab in Cholinergic Urticaria: An Exploratory Phase 2 Investigator-Initiated Study. AU - Gutsche A AU - Grabowska W AU - Altrichter S AU - Grekowitz E AU - Roll S AU - Heine G AU - Staubach P AU - Pfützner W AU - Brehler R AU - Bauer A AU - Wagner N AU - Wurpts G AU - Salameh P AU - Salehzadeh-Yazdi A AU - Jahandideh SS AU - Metz M PY - 2026 JO - Allergy DO - 10.1111/all.70454 UR - https://doi.org/10.1111/all.70454 ER -
APA
A, G., W, G., S, A., E, G., S, R., G, H., P, S., W, P., R, B., A, B., N, W., G, W., P, S., A, S., SS, J., & M, M. (2026). Dupilumab in Cholinergic Urticaria: An Exploratory Phase 2 Investigator-Initiated Study.. Allergy. https://doi.org/10.1111/all.70454
Source records
- pubmed · retrieved 2026-09-25T11:15:51.709Z
- europe-pmc · retrieved 2026-09-25T11:15:51.695Z